BofA lowered the firm’s price target on Illumina to $210 from $230 and keeps a Neutral rating on the shares after the company reported Q2 results and cut FY23 guidance. The FY23 guidance cut was “expected, but still steep,” says the firm, which voiced “uncertainty on ‘what comes next'” and lowered its FY23-25 estimates.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ILMN:
- Illumina price target lowered to $150 from $180 at Citi
- Illumina price target lowered to $200 from $225 at Credit Suisse
- Illumina price target lowered to $180 from $229 at Baird
- Illumina names Dr. Steven Barnard as Chief Technology Officer
- Illumina sees customers ‘more cautious in their purchasing’ in 2H23